NY-GLOBAL-CYBER-ALLIANCE
12.6.2024 16:01:30 CEST | Business Wire | Press release
Today, the Global Cyber Alliance and Amazon announced the launch of CyberFlex, a website that helps 18- to 25-year-olds avoid scams and cybercrimes. CyberFlex contains targeted information including free tools, interactive guides, and text alerts to prevent, mitigate, report, and recover from scams and other cyber risks. CyberFlex aims to raise awareness, shift attitudes about online risks, and provide easy steps to help young adults protect themselves and share their stories.
Developed with insights from a globally diverse group of young advisors, CyberFlex’s themes, content, and messaging are designed specifically for 18- to 25-year-olds and will be delivered on the platforms they use. Like-minded organizations are invited to support, promote, and use CyberFlex.
“We assume ‘digital natives’ can avoid scams and risks online, but data shows the opposite. Instead, they are a growing target for cybercriminals. CyberFlex engages them where they live online and provides valuable resources to build a more trustworthy Internet," said Brian Cute, GCA's Chief Operating Officer.
“Scammers that attempt to impersonate trusted brands put consumers of all ages at risk,” said Scott Knapp, Director of Worldwide Buyer Risk Prevention at Amazon. “Amazon is committed to protecting consumers from impersonation scams and is proud to continue our collaboration with the Global Cyber Alliance to provide resources that help young adults identify, avoid, and report scams. Scammers use convincing tactics to reel people in, which is why education around scam avoidance is critical to keeping consumers safe.”
A Global, Collaborative Effort
CyberFlex builds on a GCA and Amazon collaboration to foster consumer education addressing scams among young Internet users globally.
We conducted surveys, focus groups, and independent research on habits, risk perception, and awareness, knowledge, and personal experience with scams. We found that despite young adults’ online experience, they are highly susceptible to impersonation, investment, cryptocurrency scams, and other threats. The data highlighted and validated that young adults are overconfident, confused by scams, do not report incidents, and have growing privacy concerns.
GCA and Amazon will host webinars on June 18 and 26 with end users and industry partners, and a Japanese version of CyberFlex will launch later this year. Organizations interested in helping are urged to contact GCA.
About GCA
The Global Cyber Alliance (GCA) is an international nonprofit dedicated to building communities to deploy tools, services, and programs that provide cybersecurity at global scale. We achieve this in three ways: working with communities; engaging infrastructure owners and operators; and driving strategic mobilizations for collective action on cybersecurity.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240612277110/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Sofinnova Partners Closes Oversubscribed €82 Million Sofinnova MD Start IV Fund to Create the Next Generation of Medtech Companies28.9.2026 08:00:00 CEST | Press release
The new fund extends Sofinnova’s 20-year track record of company creation with capacity to launch six to eight new ventures across Europe and the US Sofinnova Partners ("Sofinnova"), a leading European life sciences venture capital firm based in Paris, London, and Milan, today announced the final close of Sofinnova MD Start IV at €82 million. The fund, which was oversubscribed, will help expand Sofinnova's medtech company-creation strategy across Europe and the US with greater capacity to launch new ventures and support them through key stages of development. With plans to launch six to eight new medtech companies over the next five years, Sofinnova MD Start IV will support ventures from inception through key clinical and operational milestones, providing founders with both capital and hands-on support. Sofinnova MD Start's approach combines clinical insight, entrepreneurial talent, and operational expertise to tackle significant unmet medical needs. The previous fund, Sofinnova MD Sta
Ant International’s Antom Upgrades Southeast Asia Leadership Structure to Drive Regional Synergy in the AI Era28.9.2026 07:18:00 CEST | Press release
Antom, a leading merchant payment and digitisation services provider under Ant International, today announced a series of key appointments for its operations in Southeast Asia to further strengthen the synergy among its regional brands and better serve regional merchants with streamlined full-stack AI-native solutions. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260927431282/en/ Nabilah Alsagoff, co-founder and former chief operating officer of DOKU, Indonesia's leading payment fintech company, has been appointed as Head of Product, Antom SEA. In her new role, the payment veteran will oversee product development and innovation and drive a unified product roadmap for the overall SEA region. Chris Yeo, former chief executive officer (CEO) of DOKU, will take on the role as Head of Antom Philippines, and Country Head of 2C2P Philippines. With his long experience at DOKU, Grab and PayPal, Chris will also oversee the execution
UAE Opens 15th UN Congress on Crime Prevention and Criminal Justice and Launches Pledge4Justice with First Pledge of Up to USD 5 Million26.9.2026 22:51:00 CEST | Press release
The 15th United Nations Congress on Crime Prevention and Criminal Justice – Abu Dhabi 2026 kicked off today at ADNEC Centre Abu Dhabi. Set to run until 1 October, the Congress attracts representatives from over 97 countries, including over 32 ministers of justice and interior ministers, alongside senior officials, judges, prosecutors, experts, and youth from around the world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260926005703/en/ UAE Opens 15th UN Congress on Crime Prevention and Criminal Justice and Launches Pledge4Justice with First Pledge of Up to USD 5 Million (Photo: AETOSWire) The opening session witnessed the adoption of the Abu Dhabi Declaration, which serves as the Congress's principal political and strategic outcome document and will guide international priorities and cooperation in crime prevention, criminal justice and the rule of law over the next five years. The Declaration is structured around four pi
Future Health Convenes Global Health Leaders at UNGA to Advance Health System Transformation at Scale26.9.2026 17:21:00 CEST | Press release
High-level dialogue explored how predictive and preventive health systems can deliver better health outcomes worldwide. Ministers, senior government representatives, and health leaders from 15 countries shared approaches to building health systems that predict risk, prevent disease, and support earlier intervention at population scale. Participants identified population-level data, financing, and delivery capacity as essential to turning earlier insight into action. Trust, community reach, and inclusive design were recognised as critical to ensuring that earlier insight and intervention are delivered effectively and equitably Future Health – A Global Initiative by Abu Dhabi convened Ministers, senior government representatives, and global health leaders in New York on the sidelines of the 81st Session of the United Nations General Assembly (UNGA 81). The high-level dialogue set out practical priorities for moving health systems from reactive treatment towards prediction, prevention, an
Mirum Pharmaceuticals and Incyte Announce U.S. FDA Approval of Atebrioz™ (zilurgisertib) for Adult and Pediatric Patients with Fibrodysplasia Ossificans Progressiva26.9.2026 01:00:00 CEST | Press release
-Once-daily oral ALK2 inhibitor approved to reduce the volume of total new heterotopic ossification in patients aged 12 years and older with FOP-Atebrioz expected to be available in the United States in October through Mirum Access Plus (MAP), with eligible patients paying as little as $0 per month-PROGRESS pediatric development program continues to evaluate zilurgisertib in children aged 2 to <12 years Mirum Pharmaceuticals, Inc. (Nasdaq:MIRM) and Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Atebrioz™ (zilurgisertib) tablets to reduce the volume of total new heterotopic ossification (HO) in adult and pediatric patients aged 12 years and older with fibrodysplasia ossificans progressiva (FOP). The recommended dose of Atebrioz is 100 mg administered orally, once daily. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260925436454/en/ “Today marks an important milestone for pe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom